Page 327 - HIVMED_v21_i1.indb
P. 327

Page 6 of 8  Original Research


              Discussion on the implications of SCH and its management   for a longer duration than their  ART-naïve counterparts,
              is ongoing. The risk of SCH is increased in PLWD, PLWHD   illustrating the  complex interactions between  ART and
              and those on ART.  3,4,8,29,30  Han et al. concluded in their meta-  increased cardiovascular risk.
              analysis that PLWD with SCH had increased diabetes-
              related complications in the form of nephropathy,     Interestingly, we found that a significant number of
              retinopathy,  peripheral arterial disease  and peripheral   HIV-infected patients developed DM after the onset of HIV
              neuropathy.  The  most important consequence of SCH   infection. The aetiology of DM in the setting of HIV can be
                       31
              remains progression to overt hypothyroidism (ranging from   attributed to either the inflammatory milieu associated
              3% to 18% annually). 32,33,34,35,36  The Rotterdam study   with the HIV infection itself, the ART or increased patient
              demonstrated  an  association  between  patients with  SCH,   longevity.  This finding underscores the importance of
                                                                           14
              aortic calcification and myocardial infarction and identified   screening for DM in HIV clinics.
              SCH as an independent risk factor for myocardial
              infarction.  Other observational studies have also found   Studies have found that the occurrence of DM in the
                      37
              associations between SCH and coronary artery disease. 38,39,40    presence of HIV infection is usually due to insulin resistance
              This association was, however, not found in the Wickham   rather than insulin deficiency and therefore is more likely to
                   41
              study.  Haentjens et al. in their analysis of seven cohort   be type 2 in nature.  Metformin use for the treatment of DM
                                                                                   13
              studies found that there was an increased risk of all-cause   in the presence of HIV has been associated with increased
              mortality in patients with SCH, more so in patients with co-  risk of developing diarrhoea and may cause lactic acidosis
                             42
              morbid conditions.  We show that SCH is associated with   in patients with renal failure. The advantages of metformin
              hyperlipidaemia. Undiagnosed SCH may affect metabolic
              control and worsen cardiovascular risk in PLWD.  43,44    use in PLWHD remains that it is an insulin sensitiser, is
                                                                                                            51
              Baseline TSH screening would help identify those patients   cost-effective and can assist with weight loss.  Insulin
              who are at higher cardiovascular risk that need closer   remains the treatment of choice in PLWHD and is endorsed
              monitoring.                                           by the American Association of Clinical Endocrinologists.
                                                                    The  benefits of using insulin is that it does not cause
              We demonstrated that over one-third (25/71, 35.21%) of our   gastrointestinal side effects and has no interactions with
              patients with SCH had TSH levels of > 10 mIU/L, and this   ART; however, insulin usage does pose increased risks of
                                                                                                                   52
              was predominantly in obese female patients with a short   hypoglycaemia and requires safe disposal of needles.
              duration of DM and HIV infection. Most authors agree that   Metformin use in patients is discouraged in PLWD and
              patients with a TSH > 10 mIU/L should be initiated onto   thyroid dysfunction as in-vitro studies using metformin
              levothyroxine therapy (LT). 45,46,47  However, 64.78% (46/71) of   have demonstrated that metformin has inhibitory effects on
                                                                                  53
              our study SCH patients had TSH levels of between 5.5 and 10   cell proliferation.  The majority (81.82%) of our PLWHD
              mIU/L, which poses a therapeutic conundrum to the     were still on metformin therapy (either monotherapy or in
              attending physician. Levothyroxine therapy in this group of   combination with other oral antidiabetic therapies or with
              patients is still very much debated in literature. Both Surks et   insulin). However, within the group of HIV-uninfected
              al. and Kong et al. found no benefit in initiation of LT in this   PLWD and thyroid dysfunction, this message of the
              TSH range, 48,49  whilst McDermott et al., Kadiyala et al. and   decreased use of metformin seemed to have been heeded,
              Fatourechi advocated that patients with SCH with co-morbid   as the majority of these patients were on insulin therapy as
              cardiovascular  conditions  be  treated  with  LT. 45,46,50   It  must   compared to metformin (6.93% vs. 4.26%, respectively).
              be  borne in mind that these studies were conducted in   This  trend  of using  insulin  instead of  metformin
              HIV-uninfected patients.                              monotherapy was also observed in the majority of patients
                                                                    with HIV infection and thyroid disorders (17.58% vs.
              Thyroid dysfunction in the form of SCH was found to be   10.31%, respectively).
              significantly more common in patients on ART therapy in
              our study (22.06%). Although less common, it must be noted   The  cohort  comprising  the  PLWHD  but  with  no  thyroid
              that thyroid disorders were also prevalent in patients who   disorders were generally female, had type 2 diabetes, were
              were ART-naïve  (14.81%). This finding has also been   younger, had a shorter duration of DM and a lower BMI with
              demonstrated by  Jain  et al. in  their study conducted in   a significant percentage having glomerular filtration  rates
              India.  Our study also found that the CD4 counts were   of  > 60 mL/min. Pillay et al. have shown previously  that
                  5
              significantly lower in patients with combined HIV infection   PLWHD were at increased risk for nephropathy.  Our
                                                                                                              54
              and thyroid disorders. The link between being on  ART,   findings of higher GFR and a greater percentage of patients
              having lower CD4 counts and thyroid dysfunction was   achieving target HbA1c can be explained by the fact that this
              also  found  in  the  study  conducted  by  Shujing  et  al.   and   cohort were younger, not obese and only had DM for a
                                                          2
              serves to highlight the importance of screening for   short  duration. Another important study finding was that
              thyroid  disorders  in  both  HIV  clinics  and  in  combined   this cohort had significantly higher total cholesterol and
              communicable–non-communicable disease (HIV-DM) clinics.   triglycerides when compared to their HIV-uninfected
              In our study, patients on  ART had higher levels of total   counterparts. Both DM and HIV are predisposing factors for
              cholesterol, triglycerides and LDL cholesterol and had HIV   cardiovascular morbidity and mortality. 43,44,55  Our findings of

                                           http://www.sajhivmed.org.za 319  Open Access
   322   323   324   325   326   327   328   329   330   331   332